Thermograph Evaluation of Masticatory and Cervical Muscles After Physiotherapeutic Treatment in Tmd Subjects
Launched by DANIELA AP. BIASOTTO-GONZALEZ · Jul 1, 2016
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
This is a randomized, placebo-controlled, study designed to evaluate the thermograms concerning the masseter and anterior temporal muscles, severity, pain, range of mandibular motion and neck disability in TMD patients, before and after physical therapy applied to the cervical and thoracic regions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 45 years;
- • presence of pain in the facial region in the last 6 months;
- • diagnosis of myofascial pain (I) and/or disc displacement (IIa and IIb) determined by the DRC/TMD; Moderate DTM Record carrier or determined by Fonseca Anamnesic Index.
- Exclusion Criteria:
- • A history of trauma/cervical surgery and/or craniofacial;
- • Neurological disorders;
- • cervical disc disease;
- • degenerative diseases of the spine;
- • systemic diseases;
- • diagnosis of fibromyalgia;
- • prior treatments for TMD for the last 3 months;
- • orthodontic treatment/orthopedic in progress;
- • continuous use of analgesics, anti-inflammatories, anxiolytics and/or antidepressants;
- • BMI\> 25 kg / m2;
- • pregnancy.
About Daniela Ap. Biasotto Gonzalez
Daniela A.P. Biasotto-Gonzalez is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through rigorous scientific investigation. With a focus on innovative therapeutic solutions, she leads initiatives that prioritize ethical standards, patient safety, and regulatory compliance. Her expertise encompasses the design, execution, and management of clinical trials across various therapeutic areas, fostering collaboration among multidisciplinary teams to drive efficient and effective research processes. Daniela's leadership is characterized by a strong commitment to transparency and excellence in clinical research, contributing to the development of transformative healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sao Paulo, , Brazil
Sao Paulo, São Paulo, Brazil
Patients applied
Trial Officials
Daniela Ap Biasotto-Gonzalez, PHD
Study Chair
Study Principal Investigator - Universidade Nove de Julho
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials